Papaioannou et al. [78] reported a correlation between elevated plasma levels of vascular endothelial growth factor (VEGF) in SSc patients and increased sPAP, though another study was not able to corroborate the association between the elevated VEGF levels and CTD-PAH [79]. Here, VEGFA is linked to systemic sclerosis.